Triple Therapy Trials in COPD: A Precision Medicine Opportunity

European Respiratory Journal - United Kingdom
doi 10.1183/13993003.01848-2018
Full Text
Abstract

Available in full text

Date
Authors
Publisher

European Respiratory Society (ERS)

Related search

Precision Medicine in COPD: Review of Mepolizumab for Eosinophilic COPD

Breathe
PulmonaryRespiratory Medicine
2018English

Progressing Precision Medicine in a World of Randomized Trials

Expert Review of Precision Medicine and Drug Development
Molecular MedicineDrug DiscoveryGeneticsPharmacology
2018English

A Functional Genomic Meta-Analysis of Clinical Trials in Systemic Sclerosis: Toward Precision Medicine and Combination Therapy

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2017English

Neuroprotection in Glaucoma: Towards Clinical Trials and Precision Medicine

Current Eye Research
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2019English

Precision Medicine Clinical Trials: Defining New Treatment Strategies

Seminars in Oncology Nursing
Oncology
2014English

Prs11 - Initiation of Triple Therapy in Newly Diagnosed Copd Patients

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Radiopharmaceutical Therapy in the Era of Precision Medicine

European Journal of Cancer
Cancer ResearchOncology
2014English

Blood-Based Biomarkers for Precision Medicine in Lung Cancer: Precision Radiation Therapy

Translational Lung Cancer Research
Oncology
2017English

Triple Therapy of Umeclidinium + Inhaled Corticosteroids/Long-Acting Beta2 Agonists for Patients With COPD: Pooled Results of Randomized Placebo-Controlled Trials

Pulmonary Therapy
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy